Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)

Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Journal of Cardiology - Volume 154, Issue 3, 9 February 2012, Pages 362-365

Jian-Jun Li, Zong-Liang Lu, Wen-Rong Kou, Roberto Bolli, Zuo Chen, Yang-Feng Wu, Xue-Hai Yu, Yu-Cheng Zhao,